Skip to main content
logo
Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
89.69
+1.69 (1.92%)
Mar 24, 2026, 10:15 AM CST

SHA:688578 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,430644.17130.5218.27
Depreciation & Amortization
38.6139.3925.2523.46
Other Amortization
1.190.791.772.42
Loss (Gain) From Sale of Assets
--0.02-0.03-
Asset Writedown & Restructuring Costs
0.010.031.71-34.53
Loss (Gain) From Sale of Investments
-36.65-32.58-45.01-66.01
Provision & Write-off of Bad Debts
0.16-0.711.360.5
Other Operating Activities
-44.15-36.02-29.534.72
Change in Accounts Receivable
-186.03-163.84-108.578.22
Change in Inventory
32.39-30.88-10.62-12.34
Change in Accounts Payable
238.62184.1467.3810.89
Change in Other Net Operating Assets
78.2675.0368.9173.69
Operating Cash Flow
1,566674.6591.6329.29
Operating Cash Flow Growth
132.12%636.28%212.82%-
Capital Expenditures
-270.22-67.88-143.83-192.25
Sale of Property, Plant & Equipment
--0-
Investment in Securities
-956.61,41681.63599.99
Other Investing Activities
-608.35-1,255-342.02-168.56
Investing Cash Flow
-1,83592.75-404.21239.19
Long-Term Debt Repaid
-2.38-2.58-4.87-8.97
Total Debt Repaid
-2.38-2.58-4.87-8.97
Net Debt Issued (Repaid)
-2.38-2.58-4.87-8.97
Common Dividends Paid
-292.5---
Other Financing Activities
-0.160.371.19-8
Financing Cash Flow
-295.05-2.21-3.69-16.97
Foreign Exchange Rate Adjustments
2.844.3517.17-3.38
Net Cash Flow
-561.36769.55-299.1248.13
Free Cash Flow
1,296606.77-52.21-162.95
Free Cash Flow Growth
113.56%---
Free Cash Flow Margin
36.42%30.06%-6.60%-30.74%
Free Cash Flow Per Share
2.881.35-0.12-0.36
Cash Income Tax Paid
566.32243.7212.82-15.03
Levered Free Cash Flow
822.62378.35-56.71-120.89
Unlevered Free Cash Flow
822.66378.45-56.5-120.51
Change in Working Capital
17759.585.5980.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.